Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Chembl4071327
| Molecular Weight | 3464.0 g/mol |
|---|---|
| Molecular Formula | C143H244N50O42S4 |
| XLogP3 | -17.2 |
| Hydrogen Bond Donor Count | 55 |
| Hydrogen Bond Acceptor Count | 55 |
| Rotatable Bond Count | 91 |
| Exact Mass | 3462.7410615 g/mol |
| Monoisotopic Mass | 3461.7377067 g/mol |
| Topological Polar Surface Area | 1610 Ų |
| Heavy Atom Count | 239 |
| Formal Charge | 0 |
| Complexity | 7860 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 28 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
| 1 of 2 | |
|---|---|
| Drug Name | Natrecor |
| PubMed Health | Nesiritide (Injection) |
| Drug Classes | Antianginal, Cardiovascular Agent |
| Active Ingredient | Nesiritide recombinant |
| Dosage Form | For solution |
| Route | Intravenous |
| Strength | 1.5mg/vial |
| Market Status | Prescription |
| Company | Scios |
| 2 of 2 | |
|---|---|
| Drug Name | Natrecor |
| PubMed Health | Nesiritide (Injection) |
| Drug Classes | Antianginal, Cardiovascular Agent |
| Active Ingredient | Nesiritide recombinant |
| Dosage Form | For solution |
| Route | Intravenous |
| Strength | 1.5mg/vial |
| Market Status | Prescription |
| Company | Scios |
Digital Content 
NEWS #PharmaBuzz
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
38
PharmaCompass offers a list of Natrecor API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Natrecor manufacturer or Natrecor supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Natrecor manufacturer or Natrecor supplier.
PharmaCompass also assists you with knowing the Natrecor API Price utilized in the formulation of products. Natrecor API Price is not always fixed or binding as the Natrecor Price is obtained through a variety of data sources. The Natrecor Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A NESIRITIDE RECOMBINANT manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of NESIRITIDE RECOMBINANT, including repackagers and relabelers. The FDA regulates NESIRITIDE RECOMBINANT manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. NESIRITIDE RECOMBINANT API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A NESIRITIDE RECOMBINANT supplier is an individual or a company that provides NESIRITIDE RECOMBINANT active pharmaceutical ingredient (API) or NESIRITIDE RECOMBINANT finished formulations upon request. The NESIRITIDE RECOMBINANT suppliers may include NESIRITIDE RECOMBINANT API manufacturers, exporters, distributors and traders.
click here to find a list of NESIRITIDE RECOMBINANT suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A NESIRITIDE RECOMBINANT DMF (Drug Master File) is a document detailing the whole manufacturing process of NESIRITIDE RECOMBINANT active pharmaceutical ingredient (API) in detail. Different forms of NESIRITIDE RECOMBINANT DMFs exist exist since differing nations have different regulations, such as NESIRITIDE RECOMBINANT USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A NESIRITIDE RECOMBINANT DMF submitted to regulatory agencies in the US is known as a USDMF. NESIRITIDE RECOMBINANT USDMF includes data on NESIRITIDE RECOMBINANT's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The NESIRITIDE RECOMBINANT USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of NESIRITIDE RECOMBINANT suppliers with USDMF on PharmaCompass.
NESIRITIDE RECOMBINANT Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of NESIRITIDE RECOMBINANT GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right NESIRITIDE RECOMBINANT GMP manufacturer or NESIRITIDE RECOMBINANT GMP API supplier for your needs.
A NESIRITIDE RECOMBINANT CoA (Certificate of Analysis) is a formal document that attests to NESIRITIDE RECOMBINANT's compliance with NESIRITIDE RECOMBINANT specifications and serves as a tool for batch-level quality control.
NESIRITIDE RECOMBINANT CoA mostly includes findings from lab analyses of a specific batch. For each NESIRITIDE RECOMBINANT CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
NESIRITIDE RECOMBINANT may be tested according to a variety of international standards, such as European Pharmacopoeia (NESIRITIDE RECOMBINANT EP), NESIRITIDE RECOMBINANT JP (Japanese Pharmacopeia) and the US Pharmacopoeia (NESIRITIDE RECOMBINANT USP).
